Compare MCRB & NXB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MCRB | NXB |
|---|---|---|
| Founded | 2010 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.2M | 49.2M |
| IPO Year | 2015 | 2025 |
| Metric | MCRB | NXB |
|---|---|---|
| Price | $2.53 | $2.09 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $17.00 | N/A |
| AVG Volume (30 Days) | ★ 72.7K | 27.0K |
| Earning Date | 11-04-2026 | 11-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $789,000.00 | ★ $119,866,298.00 |
| Revenue This Year | N/A | $41.82 |
| Revenue Next Year | N/A | $29.41 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 21.08 |
| 52 Week Low | $2.42 | $1.79 |
| 52 Week High | $29.98 | $2.57 |
| Indicator | MCRB | NXB |
|---|---|---|
| Relative Strength Index (RSI) | 21.14 | 46.06 |
| Support Level | N/A | $1.82 |
| Resistance Level | $9.53 | $2.36 |
| Average True Range (ATR) | 0.24 | 0.13 |
| MACD | -0.04 | -0.00 |
| Stochastic Oscillator | 7.70 | 26.00 |
Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.
NextBoat Inc focused on AI-powered technology platform designed to modernize and scale the world-wide pre-owned marine marketplace.